Cargando…
Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens
Adenoviruses represent the most widely used viral-vectored platform for vaccine design, showing a great potential in the fight against intracellular infectious diseases to which either there is a lack of effective vaccines or the traditional vaccination strategy is suboptimal. The extensive understa...
Autores principales: | Afkhami, Sam, Yao, Yushi, Xing, Zhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847555/ https://www.ncbi.nlm.nih.gov/pubmed/27162933 http://dx.doi.org/10.1038/mtm.2016.30 |
Ejemplares similares
-
Adenoviral-vectored next-generation respiratory mucosal
vaccines against COVID-19
por: Afkhami, Sam, et al.
Publicado: (2023) -
Adenoviruses as vectors for delivering vaccines to mucosal surfaces
por: Babiuk, L.A, et al.
Publicado: (2000) -
Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans
por: Jeyanathan, Mangalakumari, et al.
Publicado: (2022) -
Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis
por: Xing, Zhou, et al.
Publicado: (2009) -
Expression and role of VLA-1 in resident memory CD8 T cell responses to respiratory mucosal viral-vectored immunization against tuberculosis
por: Haddadi, Siamak, et al.
Publicado: (2017)